Marica Eoli
0000-0003-4744-9377
Publication & Citation Trends
Publications
0 total
High-grade gliomas with autoimmune encephalitis-like presentation: case report and systematic review of the literature
Cited by 2
Semantic Scholar
Proteomic profile of peripheral nerve sheath tumors: unraveling the different biological behaviors
Cited by 0
Semantic Scholar
Medullary thyroid carcinoma and c-cell hyperplasia in patients affected with neurofibromatosis type 1
Cited by 0
Semantic Scholar
Polyclonal expansion of functional tumor-reactive lymphocytes infiltrating glioblastoma for personalized cell therapy
Cited by 2
Semantic Scholar
CTNI-58. UPDATED RESULTS OF PHASE 3 STELLAR TRIAL: EFLORNITHINE IMPROVES OVERALL SURVIVAL AND BLINDED INDEPENDENT CENTRAL REVIEW DETERMINED PROGRESSION FREE SURVIVAL IN PATIENTS WITH RECURRENT WHO 2021 GRADE 3 IDH-MUTANT ASTROCYTOMA
Cited by 0
Semantic Scholar
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study.
Cited by 12
Semantic Scholar
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma
Cited by 1
Semantic Scholar
Research Topics
Glioma Diagnosis and Treatment
(198)
Cancer, Hypoxia, and Metabolism
(54)
Neurofibromatosis and Schwannoma Cases
(53)
Brain Metastases and Treatment
(35)
Neuroblastoma Research and Treatments
(31)
Affiliations
Uppsala University
Cedars-Sinai Medical Center
Boston Children's Hospital
Centre National de la Recherche Scientifique
Inserm